This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
Biz Dev/Licensing

Commercializing cell and gene therapies

Posted by on 15 July 2017
Share this article

New business models for clinical development and manufacturing require strategic partnerships among researchers, manufacturers and payers to fully realize the commercial opportunities.

[video src="https://www.youtube-nocookie.com/embed/nnvhUGUnqWY?rel=0"]
Moderator: Morrie Ruffin – Adjuvant Partners

  • Boro Dropulic – Lentigen Technology Inc., A Miltenyi Biotec Company
  • Miguel Mulet – TiGenix NV
  • Peter Nell – Casebia Therapeutics
Share this article

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down